Dashboard
Manage Tickers

JSPR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/24/2025 21:06:04

evercore-isi-group-maintains-outperform-on-jasper-therapeutics-lowers-price-target-to-14
Evercore ISI Group Maintains Outperform on...
09/22/2025 15:00:00

Evercore ISI Group analyst Gavin Clark-Gartner maintains Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and lowers the ...

jmp-securities-maintains-market-outperform-on-jasper-therapeutics-lowers-price-target-to-6
JMP Securities Maintains Market Outperform...
09/22/2025 13:22:25

JMP Securities analyst Silvan Tuerkcan maintains Jasper Therapeutics (NASDAQ:JSPR) with a Market Outperform and lowers the p...

btig-maintains-buy-on-jasper-therapeutics-lowers-price-target-to-7
BTIG Maintains Buy on Jasper Therapeutics,...
09/22/2025 09:36:45

BTIG analyst Justin Zelin maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price target from $20 to $7.

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
09/19/2025 12:09:04

jasper-therapeutics-announces-30m-public-offering-including-11670707-common-shares-at--243-per-share-and-675000-pre-funded-warrants-at-243-less-00001-per-share-exercise-price
Jasper Therapeutics Announces $30M Public ...
09/19/2025 04:53:38

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 21:06:10

jasper-therapeutics-announces-proposed-underwritten-public-offering-of-its-common-stock-no-financial-terms-disclosed
Jasper Therapeutics Announces Proposed Und...
09/18/2025 20:11:09

Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper"), a clinical-stage biotechnology company focused on development of br...

ubs-maintains-buy-on-jasper-therapeutics-lowers-price-target-to-25
UBS Maintains Buy on Jasper Therapeutics, ...
08/15/2025 14:21:43

UBS analyst Trung Huynh maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price target from $29 to $25.

jasper-therapeutics-q2-eps-174-misses-140-estimate
Jasper Therapeutics Q2 EPS $(1.74) Misses ...
08/13/2025 20:26:46

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(1.74) per share which missed the analyst consensus estimate of...

jasper-therapeutics-announces-50-workforce-reduction-and-strategic-refocus-on-chronic-urticaria-programs-to-extend-cash-runway-and-advance-briquilimab-development
Jasper Therapeutics Announces 50% Workforc...
07/09/2025 12:14:22

Reducing workforce by approximately 50% to focus on Chronic Urticaria programs and extend cash runwayDr. Edwin Tucker departing...

bmo-capital-downgrades-jasper-therapeutics-to-market-perform-lowers-price-target-to-4
BMO Capital Downgrades Jasper Therapeutics...
07/08/2025 17:48:59

BMO Capital analyst Kostas Biliouris downgrades Jasper Therapeutics (NASDAQ:JSPR) from Outperform to Market Perform and lowe...

jmp-securities-maintains-market-outperform-on-jasper-therapeutics-lowers-price-target-to-12
JMP Securities Maintains Market Outperform...
07/08/2025 14:11:14

JMP Securities analyst Silvan Tuerkcan maintains Jasper Therapeutics (NASDAQ:JSPR) with a Market Outperform and lowers the p...

evercore-isi-group-maintains-outperform-on-jasper-therapeutics-lowers-price-target-to-20
Evercore ISI Group Maintains Outperform on...
07/08/2025 13:02:17

Evercore ISI Group analyst Gavin Clark-Gartner maintains Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and lowers the ...

william-blair-downgrades-jasper-therapeutics-to-market-perform
William Blair Downgrades Jasper Therapeuti...
07/07/2025 21:20:51

William Blair analyst Matt Phipps downgrades Jasper Therapeutics (NASDAQ:JSPR) from Outperform to Market Perform.

hc-wainwright--co-maintains-buy-on-jasper-therapeutics-lowers-price-target-to-20
HC Wainwright & Co. Maintains Buy on Jaspe...
07/07/2025 20:47:40

HC Wainwright & Co. analyst Emily Bodnar maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price tar...

btig-maintains-buy-on-jasper-therapeutics-lowers-price-target-to-20
BTIG Maintains Buy on Jasper Therapeutics,...
07/07/2025 20:20:21

BTIG analyst Justin Zelin maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price target from $64 to $20.

jasper-therapeutics-shares-fall-on-briquilimab-drug-lot-problem
Jasper Therapeutics Shares Fall On Briquil...
07/07/2025 17:25:33

Jasper shares drop after updated BEACON study shows strong results but faces disruption from compromised drug product lot and h...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
07/07/2025 17:06:57

dow-dips-1-mustang-bio-shares-spike-higher
Dow Dips 1%; Mustang Bio Shares Spike Higher
07/07/2025 16:30:43

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION